Pfizer (PFE) reported Q1 FY 2019 earnings of $0.85 per share (versus $0.77 in Q1 FY 2018), beating analysts’ consensus of $0.75.

The company’s quarterly revenues amounted to $13.118 bln (+1.6% y/y), generally in line with analysts’ consensus estimate of $13.012 bln.

The company also raised FY 2019 EPS guidance to $2.83-2.93 from $2.82-2.92 (versus analysts’ consensus estimate of $2.89) and reaffirmed FY 2019 revenues guidance of $52.0-54.0 bln (versus analysts’ consensus estimate of $53.43 bln).

PFE rose to $40.00 (+1.04%) in pre-market trading.